Entourage Health Corp. (OTCQX: ETRGF) (TSX-V:ENTG) (FSE:4WE) revealed that holders of the company’s 8.5% unsecured convertible debentures due September 25, 2022, approved the previously announced proposed amendments to the trust indenture dated as of September 25, 2019 between TSX Trust Company and the company governing the debentures.
Approximately 97% of votes received approved the proposed amendments. Pursuant to the approvals, the indenture may be amended to, among other things: accelerate the maturity date of the debentures to June 30, 2022 and amend the cash amount payable in respect of …